MTOR and cancer: The PI3K pathway defined by PI3K, AKT and mammalian Target of Rapamycin (mTOR) controls most hallmarks of cancer, including proliferation, survival and motility, and contributes to cancer-promoting aspects of the tumor environment, such as angiogenesis [14].